Home › Diffuse Large B-Cell Lymphoma › Ohio › Columbus

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Columbus, OH

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Nagre-recruitPhase 2

Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06649812

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

The Ohio State University (OSU), Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07226843

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

The Ohio State University Wexner Medical Center, Columbus

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579

Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma

Nagre-recruitPhase 1

Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07676877

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06536049

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

The Ohio State University Wexner Medical Center James Cancer, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

The Ohio state University, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05077527

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

Nagre-recruitPhase 1

Ohio State University, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT04775745

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

Nagre-recruitPhase 1/2

The Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2022 · NCT04502394

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Columbus

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.